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Aim: To compare the outcomes of clear lens extraction and collamer lens implantation in high 
myopia.
Patients and methods: Myopic patients younger than 40 years old with more than 12 diopters 
of myopia or who were not fit for laser-assisted in situ keratomileusis were included. Group 1 
comprised patients undergoing clear lens extraction and Group 2 patients received the Visian 
implantable collamer lens. Outcome and complications were evaluated.
Results: Postoperative best corrected visual acuity was -0.61 ± 0.18 in Group 1 and 0.79 ± 0.16 
in Group 2. In Group 1, 71.4% achieved a postoperative uncorrected visual acuity better than the 
preoperative best corrected visual acuity, while only 51.8% patients achieved this in Group 2. 
Intraocular pressure decreased by 12.55% in Group 1, and increased by 15.11% in Group 2. Cor-
neal endothelial cell density decreased by 4.47% in Group 1 and decreased by 5.67% in Group 2. 
Posterior capsule opacification occurred in Group 1. In Group 2, lens opacification occurred in 
11.11%, significant pigment dispersion in 3.7%, and pupillary block glaucoma in 3.7%.
Conclusion: Clear lens extraction presents less of a financial load up front, and less likelihood 
of the need for a secondary intervention in the future. Clear lens extraction is a more viable 
solution in developing countries with limited financial resources.
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Introduction
The personal and socioeconomic impact of myopia is well documented.1,2 The poor 
visual quality of spectacle-corrected high emmetropia with inherent optical aberrations, 
secondary psychologic problems, and frequent intolerance to contact lenses, justify 
the search for new technology in the correction of high ametropia.3
Surgical correction of high ametropia is a controversial issue.4–7 Despite the 
  widespread acceptance of laser-assisted in situ keratomileusis (LASIK) within the 
  ophthalmic community, this moderately invasive technique that directly affects 
the clear, central, optical zone is associated with a sizeable number of potential 
  intraoperative and postoperative complications, the incidence of which has been 
found to increase with higher refractive errors.8 To this contributes the fact that the 
use of Excimer laser corneal ablation has some limitations concerning the amount of 
corneal tissue that can be removed,9 the predictability and stability of photorefractive 
techniques decreases with the amount of attempted correction, and corneal ectasia 
might occur as a result of large ablation depths.10 Additionally, altering the shape of 
the cornea in attempted high photorefractive corrections may result in poor quality 
of vision.11Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Fukala is considered the pioneer of clear lens   extraction 
(CLE) for the correction of myopic eyes.12 Extracting the clear 
lens is one procedure that has been used to treat high myopia for 
a long time.13,14 The primary concern with this procedure is its 
association with an increased risk of retinal complications.14,15 
CLE is an invasive procedure that can result in severe visual 
loss. Albeit rare, the primary risk is an increased potential 
for retinal detachment. Other potential complications include 
cystoids, macular edema, and endophthalmitis. Despite 
these severe complications, advances in surgical techniques 
have led surgeons to   reconsider this option and to weigh the 
risks against the benefits of the procedure.16
Phakic intraocular implants can correct high myopia 
and hyperopia, with the advantages of reversibility,   stability 
of the correction, and to a great extent, preservation of 
accommodation.8,17–26 An increasing number of procedures 
are being performed because of the expectation of a superior 
quality of vision obtained with phakic intraocular lens (IOL) 
implantation with respect to keratorefractive surgery for the 
correction of high ametropias.27–30 However, induced cataract 
and glaucoma are at the heart of most concerns regarding 
these intraocular surgical procedures, especially for posterior 
chamber phakic IOLs.31–39 This study was conducted with the 
aim of comparing CLE and the implantable collamer lens 
(ICL) in correction of high myopia in the patients younger 
than 45 years.
Patients and methods
Patient selection and preparation
This was a prospective, nonrandomized interventional study 
carried out on 55 eyes in 31 patients seeking   treatment of 
myopia. The research followed the tenets of the   Declaration 
of Helsinki, and informed consent was obtained from patients, 
to whom all details of the procedure were explained, with 
emphasis on the intended outcome. The research was approved 
by the El-Nour Eye Hospital institutional review board.
Inclusion criteria were myopia of more than 12 diopters, 
myopia of less than 12 diopters if the patients were unsuitable 
for LASIK due to topography or pachymetry results   according 
to guidelines suggested in literature, and age younger 
than 45 years (to obtain some accommodative potential). 
  Exclusion criteria were intraocular pressure (IOP) outside the 
  statistically normal range (more than 21 mmHg), presence of 
iris   transillumination defects, or retinal pathology.
After appropriate counseling and signing of informed con-
sent, the personal treatment preferences of the patients were 
taken into account with regard to their assignment to either 
group. Group 1 underwent CLE and Group 2   underwent ICL. 
CLE was preferred if there was a recent increase in myopia 
by more than 1.0 diopter, an anterior chamber depth (ACD) 
less than 2.8 mm, or if the patient was unable to afford 
ICL. ICL was undertaken in patients motivated to maintain 
their residual accommodation provided their refraction was 
stable, the anterior chamber was more than 2.8 mm deep, 
and adequate financial resources were available.
The  preoperative  evaluation  included  manifest 
and cycloplegic refraction, uncorrected (UCVA) and 
best-corrected visual acuity (BCVA) measured on a visual 
chart and expressed as Snellen’s decimal, intraocular pressure 
(IOP) measurement by Goldmann applanation tonometry, 
through slit lamp biomicroscopy of the anterior segment, 
and dilated fundus examination using both a 90 diopters (D) 
lens for the posterior pole and a three-mirror lens for detailed 
examination of the retinal periphery.
Preoperative specular microscopy using the noncontact 
specular microscope (NONCON ROBO-P, Konan Medical, 
Torrance, CA) was done and repeated six months postop-
eratively. ACD, horizontal white to white diameter and 
corneal topography were measured using anterior segment 
scheimpflug imaging by Pentacam HR (OCULUS Optik-
geräte GmbH, Germany). ICL diameter, power, and optic 
size calculation were performed by STAAR Surgical Inc.
(Monrovia, CA), using a modified vertex formula based on 
the above diameters with targeted postoperative emmetropia 
and adequate lens vaulting.
Surgical technique
All CLE procedures were performed by AE and MH who 
are experienced anterior segment surgeons, while all ICL 
  procedures were performed by HY who had performed numer-
ous ICL implantations prior to commencement of the study.
Clear lens extraction
All surgeries were performed under local peribulbar   anesthesia 
through a 3.2 mm incision placed along the steeper meridian 
and the creation of two side ports. Because of the soft nucleus, 
often only irrigation/aspiration was used. A foldable hydropho-
bic acrylic IOL (SENSAR Acrylic IOL with OptiEdge, Abbott 
Medical Optics, Inc., Abbott Park, IL) was introduced through 
an injector without widening the wound, into the capsular bag, 
with meticulous polishing of the anterior lens capsule.
Implantable collamer lens
All surgeries were performed under local peribulbar 
  anesthesia through a 3.2 mm incision placed along the 
steeper meridian and the creation of a single side port. The Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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anterior chamber was filled with an ophthalmic viscosurgical 
device (OVD). Careful loading of the ICL into the cartridge 
was undertaken using special microforceps and with partial 
lubrication using a mixture of saline and OVD to eliminate 
electrostatic forces. The lens was then slowly injected into 
the anterior chamber using the STAAR injector (STAAR 
  Surgical Inc) anterior to the iris plane, and allowed to unfold. 
The positioning holes on the distal and proximal footplates 
of the lens were checked to ensure proper orientation. The 
lens was rotated to be in the horizontal anterior chamber posi-
tion. Each corner of the footplate was tucked beneath the iris 
carefully with a modified lens spatula, taking special care not 
to touch the optic or the crystalline lens. Once the lens was 
placed, the OVD was removed by irrigation/aspiration, taking 
care not to leave any residue. The pupil was pharmacologi-
cally constricted and a peripheral iridectomy performed at 
12 o’clock using a vitrectomy probe. The wound was secured 
by stromal hydration.
Postoperative care
Topical antibiotic (gatifloxacin 0.3% three times a day) and 
steroids (prednisolone 1% five times a day) were administered 
and gradually tapered over a period of four weeks. The ICL 
group also received oral acetazolamide 250 mg twice daily 
during the first 24 hours.
Outcome parameters
The mean follow-up period was 17.1 ± 8.56 months. 
  During this period the patients were examined on the first 
  postoperative day, and at one week, two weeks, one month, 
and quarterly thereafter until the end of follow-up. During this 
period the assessed outcome parameters included last visit 
UCVA,   refraction and BCVA, IOP (with the   measurement 
taken at six months being representative of the postoperative 
reading), noncontact specular microscopy at six months, 
Pentacam evaluation of ACD, other postoperative complica-
tions, and the need for a secondary procedure. The ICL group 
additionally had slit lamp examination for inflammation and 
lens opacities.
Statistical analysis
Data were described using the arithmetic mean ± SD or   number 
and percentage when appropriate. Comparison of variables was 
done using the Mann–Whitney U test and Wilcoxon single-
rank test for between-group comparisons and comparisons 
within the same group, respectively. All tests were two-tailed, 
and a P value , 0.05 was considered   statistically significant. 
All statistical calculations were done using the SPSS (version 
10.0; SPSS Inc., Chicago, IL) statistical program.
Results
Patient population
Group 1 involved 28 eyes in 16 patients, with 12 patients 
being operated bilaterally and four patients unilaterally, and 
a mean age of 36.04 ± 3.95. Group 2 involved 27 eyes in 
15 patients, with three patients being operated   unilaterally, 
and a mean age of 29.26 ± 6.82 (see Table 1). The age was 
significantly different (P = 0.000) between the groups, but 
this can be explained by the inclusion criteria. Group 1 
involved eight male and eight female patients, while Group 2 
involved six male and nine female patients.
Predictability
The mean preoperative spherical equivalent (SEQ) was 
-17.54 ± 4.99 D in the CLE group and -16.45 ± 2.64 
D in the ICL group. The difference was   statistically 
Table 1 Summary of patient data
CLE ICL Sig
Min Max Mean SD Min Max Mean SD
Age 29 42 36.04 3.95 20 40 29.26 6.82 0.000
Pre-UCVA 0.02 0.08 0.041 0.018 0.02 0.16 0.36 0.027 0.072
Post-UCVA 0.10 0.70 0.43 0.16 0.20 0.70 0.44 0.16 0.662
Pre-BCVA 0.20 0.60 0.39 0.097 0.30 0.70 0.51 0.087 0.000
Post-BCVA 0.10 0.90 0.61 0.18 0.30 1.00 0.79 0.16 0.000
Pre-ECD 2784 3876 3258.54 295.29 2784 3332 3070 152.35 0.005
Post-ECD 2623 3781 3112.79 304.13 2634 3187 2896 151.75 0.002
Pre-SEQs –8 –27 –17.54 4.99 –10 -22 –16.45 2.64 0.319
Post-SEQs –2.50 1.00 –0.99 0.88 –2.00 1.25 –0.63 0.86 0.199
Pre-IOP 10 22 16.25 3.34 11 22 16.15 3.21 0.909
Post-IOP 9 25 14.21 3.75 13 24 18.59 2.74 0.000
Abbreviations: BCVA, best-corrected visual acuity; CLE, clear lens extraction; ECD, endothelial cell density; ICL, implantable collamer lens; IOP, intraocular pressure;   
SEQ, spherical equivalent; Max, maximum; Min, minimum; SD, standard deviation; Sig, significant; UBVA, uncorrected best visual acuity.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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  insignificant (P = 0.32). The mean   postoperative SEQs 
were -0.99 ± 0.88 D in the CLE group and -0.63 ± 0.86 
D in the ICL group. The difference was statistically 
  insignificant (P = 0.199).
The refractive results were compared with the desired 
postoperative refraction. In the CLE group the aim was 
residual myopia of -1.00 D; 82% (23 patients) were 
within ±1.00 D of the desired refraction, and 100% were 
within ±2.00 D. In the ICL group the aim was emmetropia; 
77% (20 patients) were within ±1.00 D of the desired refrac-
tion, and 100% were within ±2.00 D. The investigators aimed 
for emmetropia in the ICL group because these patients 
retained some residual accommodative potential, but aimed 
for a myopia of -1.00 in the CLE group because patients 
who are previously myopes are seldom happy if they become 
emmetropic with loss of accommodation.
Visual outcome
The mean preoperative BCVA was 0.39 ± 0.097 in the CLE 
group and 0.51 ± 0.87 in the ICL group. The difference was 
statistically significant (P = 0.000). The mean postoperative 
BCVA was 0.61 ± 0.18 in the CLE group and 0.79 ± 0.16 
in the ICL group. The difference was statistically   significant 
(P = 0.000). However, comparisons within each group 
revealed a different aspect. In the CLE group, 20 patients 
(71.4%) achieved a postoperative UCVA better than their 
preoperative BCVA, while only 14 (51.8%) patients achieved 
this in the ICL group. In the CLE group, 15 patients (53.5%) 
achieved a postoperative UCVA $ 0.5 versus 12 patients 
(44.4%) in the ICL group.
Anatomic outcome
In the CLE group, the mean IOP showed a reduction 
from a   preoperative value of 16.25 ± 3.34 mmHg to a 
postoperative value of 14.21 ± 3.75 mmHg. This shift 
was significant (P , 0.001). On the other hand, the ICL 
group showed an elevation of mean IOP from a preopera-
tive value of 16.15 ± 3.21 mmHg to a postoperative value 
of 18.59 ± 2.74 mmHg. This shift was again significant 
(P , 0.001).
Corneal endothelial cell density (ECD) showed a differ-
ence between the preoperative and postoperative values of 
4.47% in the CLE group and 5.67% in the ICL group. ACD 
was evaluated only in the ICL group, this evaluation being 
performed at six months. The mean preoperative ACD of 
3.18 ± 0.14 mm (range 2.99–3.42) was significantly reduced 
to 2.99 ± 0.17 mm (range 2.75–3.3). The P value for this 
variable was ,0.001.
Complications
None of the cases in either series had significant corneal haze 
or edema, retinal detachment, endophthalmitis, or persistent 
inflammation during the follow-up period.
There were no notable complications in the CLE group, 
apart from the occurrence of posterior capsule   opacification 
and the need for neodymium-doped yttrium aluminum 
garnet (Nd:YAG) capsulotomy. This occurred in four eyes 
(14.3%).
A number of complications were noted in the ICL group. 
Three forms of lens opacity were evaluated   postoperatively, 
ie, anterior subcapsular opacity, nuclear opacity, and 
  posterior subcapsular opacity. Evaluation was done under 
the slit lamp after pupillary dilation. Lens opacity was con-
sidered to be significant if it caused a loss of .two lines 
of BCVA. Overall lens opacity was noted in three eyes 
(11.11%). Only one eye had significant lens opacity, with 
both anterior subcapsular and nuclear opacity related to a 
secondary glaucoma procedure and required cataract extrac-
tion (see Table 2). Lens opacity was analyzed regarding 
age, gender, degree of myopia, and adequate ICL vaulting. 
Lens opacity was not significantly related to age and gender, 
but significantly related to the degree of myopia (all had 
myopia .18 D)
Significant pigment dispersion occurred in one eye 
(3.7%), with a rise of IOP (.21 mmHg). Ultrasonic bio-
microscopy examination revealed ICL iris contact at the 
superior-temporal quadrant, requiring a second procedure in 
the form of lens rotation to exact horizontal meridian which 
achieved marked improvement.
One eye developed pupillary block glaucoma in the early 
postoperative period with evident pigment blocking the 
iridotomy, requiring glaucoma surgery and with a rapidly 
progressing cataract that eventually required ICL removal, 
cataract extraction with placement of low power monofocal 
posterior chamber IOL, and with a final UCVA better than 
the preoperative BCVA for distance work.
One eye (3.7%) had a macular dot hemorrhage with a 
drop of BCVA . two lines, with no fluorescein angiographic 
evidence of choroidal neovascular membrane, and with 
spontaneous clearance and improvement of visual acuity to 
one line less the preoperative BCVA.
Table 2 Incidence of postoperative lens opacity
Clinically insignificant Clinically significant
Anterior subcapsular 1 (3.7%) 1 (3.7%)
Nuclear opacity 0 1 (3.7%)
Posterior subcapsular 1 (3.7%) 0Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
451
Treament of high myopia
Discussion
In this series we tried to compare CLE and ICL for 
  predictability, and visual and anatomic outcome for the 
treatment of high myopia. Both procedures showed a high 
predictability, with a higher percentage of cases achieving 
the target   refraction in the CLE group than in the ICL group, 
although the difference was marginal (82% versus 77%).
The mean postoperative BCVA was 0.61 ± 0.18 in the 
CLE group and 0.79 ± 0.16 in the ICL group. The difference 
was statistically significant (P = 0.000). We attributed this to 
the higher range of error in the CLE group (highest error was 
-27 D versus 22 D) and consequently the retinal condition 
was correspondingly weaker.
The first anatomic outcome to consider is the IOP. In 
the CLE group, the mean IOP showed a reduction from a 
  preoperative value of 16.25 ± 3.34 mmHg to a postopera-
tive value of 14.21 ± 3.75 mmHg. This shift was significant 
(P , 0.001). Several studies have documented a change 
in IOP and ACD after cataract extraction.40–44 Increases 
and decreases in IOP often occur postoperatively. There 
are several explanations for the reduction in IOP after 
phacoemulsification and IOL implantation. One reason is 
decreased resistance to aqueous humor outflow caused by 
an increase in ACD, although other mechanisms are also 
responsible for aqueous humor outflow. Postoperative release 
of endogenous prostaglandin F2 after cataract extraction is 
reported to enhance uveoscleral outflow. Reduced IOP may 
also be associated with hyposecretion of aqueous humor by 
increasing traction on the ciliary body via the ciliary zonular 
fibers due to postoperative fibrosis and contraction of the 
lens capsule.40
On the other hand, the ICL group showed an elevation of 
mean IOP from a preoperative value of 16.15 ± 3.21 mmHg 
to a postoperative value of 18.59 ± 2.74 mmHg. This shift 
was again significant (P , 0.001). Reasons for this elevated 
IOP include forward vaulting of the ICL and consequently 
of the iris, highly myopic eyes being prone to developing 
chronic open angle glaucoma, or presence of pigment in 
the trabeculum.45 In our series, one eye (3.7%) had pigment 
dispersion, and one eye (3.7%) had pupillary block glaucoma 
in the early postoperative period, with evident pigment 
blocking the   iridotomy, requiring glaucoma surgery with 
rapidly progressing cataract that eventually required ICL 
removal and cataract extraction with placement of a posterior 
chamber IOL.
The second anatomic outcome to consider is the ECD. 
The drop in ECD was less in the CLE than in the ICL group 
(4.47% versus 5.67%, respectively). The cause of   endothelial 
cell loss after phakic IOL implantation is multifactorial. 
After any surgical procedure in the anterior segment, ECD 
decreases in proportion to the time of surgery and the type 
of procedure.46 Progressive endothelial cell loss has been 
suggested to be the result of a chronic, smoldering uveitis 
associated with IOLs. Chronic subclinical inflammation has 
also been observed in phakic eyes with IOLs.47 It has been 
suggested that while endothelial cell loss continued over the 
first three years of follow-up (2%–3% per year), there was 
a cell increase of 0.1% between three years and four years, 
suggesting that endothelial remodeling and stability may 
have occurred.48
Although multiple factors influence the side effect profile 
of phakic IOLs, the majority of complications can   generally be 
predicted by the design and location of the phakic IOL within 
the anterior segment. The closer the phakic IOL comes to the 
corneal endothelium, angle structures, or crystalline lens, the 
greater the risk of endothelial cell loss, iris   complications, and 
cataract, respectively. In addition to the inherent problems 
from phakic IOL designs, appropriate sizing of the phakic 
IOL, surgeon inexperience, and surgical trauma, as well as 
other patient-specific factors can contribute to intraoperative 
and postoperative complications. A comprehensive review 
and grouped analysis of phakic IOL complications and pos-
sible causes can be found elsewhere.49
Previous reports of posterior chamber phakic IOL surgery 
report an incidence of lens opacity from 1.5% to 25%.23,50,51 
Some of the variation may be due to the   definition of   cataract 
or opacity and the follow-up period, as well as surgical 
technique. In our series, lens opacity was noted in three eyes 
(11.11%). Only one eye had significant lens opacity, with both 
anterior subcapsular and nuclear   opacity related to a   secondary 
glaucoma procedure and cataract   extraction. Several fac-
tors can play a role in the   opacification of the   crystalline 
lens, ie, surgical trauma, postoperative   inflammation, use 
of topical steroids, and contact between the phakic IOL and 
the crystalline lens. Of these, one can postulate that phakic 
posterior chamber IOL implantation in eyes with early nuclear 
changes might promote the progression of these changes into 
the development of a clinically significant nuclear cataract.52 
The thickness of the crystalline lens increases as the eye ages, 
and this may lead to transient or permanent contact. It can be 
hypothesized that implantation of phakic IOLs in patients in 
their 40s or 50s may increase the trend to develop cataracts 
earlier than in nonmyopic eyes.53
The increasing incidence of phakic intraocular procedures 
warrants education regarding management and prevention 
of potential complications. It may be advisable to perform Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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preoperative biometry and axial length measurements on all 
patients undergoing phakic IOL implantation to be prepared 
for the future need of phacoemulsification.54
The main concern when operating on myopic eyes is 
  retinal detachment with the attendant risk for significant 
visual loss. Retinal detachment secondary to cataract 
  extraction originates from the loss and advancement of 
the vitreous, which is often characterized by structural 
  modifications in myopic patients. These include massive 
colliquation, vitreoschisis, and fibrous organization, with 
consequent vitreoretinal traction. It is therefore important 
that the barrier provided by the capsular-zonular plane remain 
intact, and IOL implantation is always advisable.55 In our 
series of CLE, only four eyes required Nd:YAG capsulotomy, 
and none of the patients developed retinal detachment. We 
attributed this to careful preoperative screening using three-
mirror examination, avoiding doubtful cases, very careful 
polishing of the posterior capsule and the anterior leaf of the 
capsule to remove epithelial cells, our choice of IOL with 
an edge design believed to retard the occurrence of posterior 
capsule opacification, and a relatively short follow-up period 
of 17.1 ± 8.56 months. The incidence of this complication 
after CLE reported in other studies13,15,56 is variable, ranging 
from 0% to 8%. It has been proposed that the causes of this 
variability are different patient characteristics and study 
designs. These and other previously reported studies have 
found associations between the risk of retinal detachment and 
one or more of several factors, including younger age, axial 
length, history of retinal detachment or surgery in the con-
tralateral eye or lesions predisposing to retinal detachment, 
surgical technique and integrity of the posterior capsule, use 
of Nd:YAG capsulotomy, and longer follow-up time after 
surgery. Several papers have reported the incidence and 
characteristics of retinal detachment in patients with severe 
myopia corrected by phakic anterior chamber IOL implanta-
tion. An incidence of retinal detachment from 0.61% to 4.8% 
has been reported.17,57–60 No cases occurred in our series.
The choice of the procedure presents a challenge to the 
clinician to provide adequate informed consent. This is due 
to two factors, ie, the greater complexity of optical issues 
and the greater range of options that are available now and 
may be available in the future. The informed consent process 
involves appropriately informing patients of risks, benefits, 
and alternatives to the proposed procedure(s). Explaining the 
range of visual outcomes to patients is not for the clinician in 
a hurry. And neither is explaining the risks. There are obvious 
rare but severe risks with CLE, including retinal detachment 
and endophthalmitis. Equally important, however, is the 
  discussion of quality of vision, including the possible failure to 
achieve adequate near vision, and the compromise associated 
with monovision, halos, and reduced contrast sensitivity. With 
ICL there is the risk of developing cataract and secondary 
glaucoma, so clarifying patient expectations is crucial.
Another issue that also needs to be taken into account is 
cost. The cost of surgery in CLE and ICL is the same, apart 
from the lens, which is the only different consumable. The 
cost of the ICL is several-fold higher than that of a high-
quality foldable injectable acrylic hydrophobic IOL. This 
is an important factor in developing countries and in some 
developed regions where ICL is considered to be a cosmetic 
procedure and therefore not funded. An additional factor to 
consider is the personal experience of the surgeon, because 
the ICL requires additional training, whereas CLE extraction 
is a variation of a more common procedure.
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